StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB opened at $0.04 on Monday. The company has a 50-day simple moving average of $0.04 and a 200-day simple […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB stock opened at $0.04 on Monday. The stock’s fifty day moving average is $0.04 and its 200-day […]
Analysts at StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance Navidea Biopharmaceuticals stock opened at $0.04 on Friday. Navidea Biopharmaceuticals has a twelve month low of […]
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NAVB opened at $0.04 on Friday. The firm has a market capitalization of $3.95 million, a price-to-earnings ratio […]
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published on Thursday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Navidea Biopharmaceuticals stock opened at $0.04 on Thursday. The firm has a market capitalization of $4.09 million, a PE ratio of -0.68 and […]